According to the latest financial report of Praxis Precision Medicines, the latest earnings per share (TTM) for the company is -2.75. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about Praxis Precision Medicines's free cash flow? The latest report shows it as -27.50M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Praxis Precision Medicines shows that the company's current ratio is 10.96, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Praxis Precision Medicines, the quick ratio is 10.86, indicating that the company can meet its short-term debt obligations.
Want to learn more about the financial health of Praxis Precision Medicines? The latest ROE figure is -12.95%, indicating that the company has stable profitability.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Praxis Precision Medicines, the total asset return on investment (ROA) is -12.11%.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Praxis Precision Medicines's latest financial report to see how their gross margin is doing - currently at --.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Praxis Precision Medicines, the net profit margin is -17.19K%, which is a good sign for its profitability.